Abstract
The quality of magnetic resonance (MR) angiography could be substantially improved over the past several years based on the introduction and application of parallel imaging, new sequence techniques, such as, e.g., centric k-space trajectories, dedicated contrast agents, and clinical high-field scanners. All of these techniques have played an important role to improve image resolution or decrease acquisition time for the dedicated examination of a single vascular territory. However, whole-body MR angiography may be the application with the potential to profit most from these technical advances. The present review article describes the technical innovations with a focus on parallel imaging at high field strength and the impact on whole-body MR angiography. The clinical value of advanced whole-body MR angiography techniques is illustrated by characteristic cases.
Similar content being viewed by others
References
Nael K, Ruehm SG, Michaely HJ et al (2006) High spatial-resolution CE-MRA of the carotid circulation with parallel imaging: comparison of image quality between two different acceleration factors at 3.0 Tesla. Invest Radiol 41:391–399
Anzalone N, Scomazzoni F, Castellano R et al (2005) Carotid artery stenosis: intraindividual correlations of 3D time-of-flight MR angiography, contrast-enhanced MR angiography, conventional DSA, and rotational angiography for detection and grading. Radiology 236:204–213
Riedy G, Golay X, Melhem ER (2005) Three-dimensional isotropic contrast-enhanced MR angiography of the carotid artery using sensitivity-encoding and random elliptic centric k-space filling: technique optimization. Neuroradiology 47:668–673
Nederkoorn PJ, Elgersma OEH, van der Graaf Y, Eikelboom BC, Kappelle LJ, Mali WPTM (2003) Carotid artery atenosis: accuracy of contrast-enhanced MR angiography for diagnosis. Radiology 228:677–682
Kroencke TJ, Wasser MN, Pattynama PMT et al (2002) Gadobenate Dimeglumine-enhanced MR angiography of the abdominal aorta and renal arteries. Am J Roentgenol 179:1573–1582
Billaud Y, Beuf O, Desjeux G, Valette PJ, Pilleul F (2005) 3D contrast-enhanced MR angiography of the abdominal aorta and its distal branches: interobserver agreement of radiologists in a routine examination. Acad Radiol 12:155–163
Prince MR, Narasimham DL, Stanley JC et al (1995) Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 197:785–792
Rofsky NM, Johnson G, Adelman MA, Rosen RJ, Krinsky GA, Weinreb JC (1997) Peripheral vascular disease evaluated with reduced-dose gadolinium-enhanced MR angiography. Radiology 205:163–169
Owen RS, Baum RA, Carpenter JP, Holland GA, Cope C (1993) Symptomatic peripheral vascular disease: selection of imaging parameters and clinical evaluation with MR angiography. Radiology 187:627–635
Nelemans PJ, Leiner T, de Vet HCW, van Engelshoven JMA (2000) Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Radiology 217:105–114
Maki JH, Wilson GJ, Eubank WB, Hoogeveen R (2002) Utilizing SENSE to achieve lower station sub-millimeter isotropic resolution and minimal venous enhancement in peripheral MR angiography. J Magn Reson Imaging 15:484–491
Goyen M, Quick HH, Debatin JF et al (2002) Whole-body three-dimensional MR angiography with a rolling table platform: initial clinical experience. Radiology 224:270–277
Ruehm SG, Goyen M, Barkhausen J et al (2001) Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet 357:1086–1091
Kramer H, Schoenberg SO, Nikolaou K et al (2005) Cardiovascular screening with parallel imaging techniques and a whole-body MR imager. Radiology 236:300–310
Fenchel M, Scheule AM, Stauder NI et al (2006) Atherosclerotic disease: whole-body cardiovascular imaging with MR system with 32 receiver channels and total-body surface coil technology-initial clinical results. Radiology 238:280–291
Kruger DG, Riederer SJ, Grimm RC, Rossman PJ (2002) Continuously moving table data acquisition method for long FOV contrast-enhanced MRA and whole-body MRI. Magn Reson Med 47:224–231
Quick HH, Vogt FM, Madewald S et al (2004) High spatial resolution whole-body MR angiography featuring parallel imaging: initial experience. Fortschr Röntgenstr 176:163–169
Fenchel M, Requardt M, Tomaschko K et al (2005) Whole-body MR angiography using a novel 32-receiving-channel MR system with surface coil technology: first clinical experience. J Magn Reson Imaging 21:596–603
Vogt FM, Ajaj W, Hunold P et al (2004) Venous compression at high-spatial-resolution three-dimensional MR angiography of peripheral arteries. Radiology 233:913–920
Bilecen D, Schulte AC, Aschwanden M et al (2004) MR angiography with venous compression. Radiology 233:617–618
Nael K, Michaely HJ, Villablanca P, Salamon N, Laub G, Finn JP (2006) Time-resolved contrast enhanced magnetic resonance angiography of the head and neck at 3.0 Tesla: initial results. Invest Radiol 41:116–124
Nael K, Villablanca JP, Pope WB, McNamara TO, Laub G, Finn JP (2007) Supraaortic arteries: contrast-enhanced MR angiography at 3.0 T-highly accelerated parallel acquisition for improved spatial resolution over an extended field of view. Radiology 242:600–609
Fenchel M, Nael K, Ruehm S, Finn JP, Miller S, Laub G (2006) Isotropic high spatial resolution magnetic resonance angiography of the supra-aortic arteries using two-dimensional parallel imaging (iPAT2) at 3 Tesla: a feasibility study. Invest Radiol 41:545–552
Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA (2007) Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 188:586–592
Steg PG, Bhatt DL, Wilson PW et al (2006) One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297:1197–1206
Bhatt DL, Steg PG, Ohman EM et al (2006) International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295:180–189
Smith TP, Cragg AH, Berbaum KS, Nakagawa N (1992) Comparison of the efficacy of digital subtraction and film-screen angiography of the lower limb: prosepctive study in 50 patients. Am J Roentgenol 158:431–436
Malden ES, Picus D, Vesely TM, Darcy MD, Hicks ME (1994) Peripheral vascular disease: evaluation with stepping DSA and conventional screen-film angiography. Radiology 191:149–153
von Kemp K, van den Brande P, Peterson T et al (1997) Screening for concomitant diseases in peripheral vascular patients. Results of a systematic approach. Int Angiol 16:114–122
Cheng SWK, Wu LLH, Lau H, Wong J (1999) Screening for asymptomatic carotid stenosis in patients with peripheral vascular disease: a prospective study and risk factor analysis. Cardiovasc Surg 7:303–309
Goyen M, Goehde SC, Herborn CU et al (2004) MR-based full-body preventative cardiovascular and tumor imaging: technique and preliminary experience. Eur Radiol 14:783–791
Antoch G, Vogt FM, Freudenberg LS et al (2003) Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290:3199–3206
Hoogeveen RM, Bakker CJ, Viergever MA (1998) Limits to the accuracy of vessel diameter measurement in MR angiography. J Magn Reson Imaging 8:1228–1235
Westenberg JJ, van der Geest RJ, Wasser MN et al (2000) Vessel diameter measurements in gadolinium contrast-enhanced three-dimensional MRA of peripheral arteries. Magn Reson Imaging 18:13–22
Vasbinder GB, Maki JH, Nijenhuis RJ et al (2002) Motion of the distal renal artery during three-dimensional contrast-enhanced breath-hold MRA. J Magn Reson Imaging 16:685–696
Born M, Willinek WA, Gieseke J, von Falkenhausen M, Schild H, Kuhl CK (2005) Sensitivity encoding (SENSE) for contrast-enhanced 3D MR angiography of the abdominal arteries. J Magn Reson Imaging 22:559–565
Hayes CE, Hattes N, Roemer PB (1991) Volume imaging with MR phased arrays. Magn Reson Med 18:309–319
Hayes CE, Roemer PB (1990) Noise correlations in data simultaneously acquired from multiple surface coil arrays. Magn Reson Med 16:181–191
Roemer PB, Edelstein WA, Hayes CE, Souza SP, Mueller OM (1990) The NMR phased array. Magn Reson Med 16:192–225
Pruessmann KP, Weiger M, Scheidegger MB, Bydder M (1999) SENSE: Sensitivity encoding for fast MRI. Magn Reson Med 42:952–962
Wen H, Denison TJ, Singerman RW, Balaban RS (1997) The intrinsic signal-to-noise ratio in human cardiac imaging at 1.5, 3, and 4 T. J Magn Reson 125:65–71
Sodickson DK, Manning WJ (1997) Simultaneous acquisition of spatial harmonics (SMASH): fast imaging with radiofrequency coil arrays. Magn Reson Med 38:591–603
Bammer R, Schoenberg SO (2004) Current concepts and advances in clinical parallel magnetic resonance imaging. Top Magn Reson Imaging 15:129–158
Ohliger MA, Grant AK, Sodickson DK (2003) Ultimate intrinsic signal-to-noise ratio for parallel MRI: electromagnetic field considerations. Magn Reson Med 50:1018–1030
Wiesinger F, Boesiger P, Pruessmann KP (2004) Electrodynamics and ultimate SNR in parallel MR imaging. Magn Reson Med 52:376–390
de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC (2004) MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 230:652–659
Schmitt F, Grosu D, Mohr C et al (2004) 3 Tesla MRI: successful results with higher field strengths. Radiologe 44:31–47
Reimer P, Müller M, Marx C et al (1998) T1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555 A: dependence on field strength and plasma concentration-preliminary clinical experience with dynamic T1weighted MR imaging. Radiology 209:831–836
Bernstein MA, Huston J III, Lin C, Gibbs GF, Felmlee JP (2001) High-resolution intracranial and cervical MRA at 3.0 T: technical considerations and initial experience. Magn Reson Med 46:955–962
Nezafat R, Stuber M, Ouwerkerk R, Gharib AM, Desai MY, Pettigrew RI (2006) B1-insensitive T2 preparation for improved coronary magnetic resonance angiography at 3 T. Magn Reson Med 55:858–864
Nael K, Saleh R, Nyborg GK et al (2007) Pulmonary MR perfusion at 3.0 Tesla using a blood pool contrast agent: Initial results in a swine model. J Magn Reson Imaging 25:66–72
Pintaske J, Martirosian P, Graf H et al (2006) Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol 41:213–221
Runge VM, Biswas J, Wintersperger BJ et al (2006) The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model. Invest Radiol 41:244–248
Kim JK, Farb RI, Wright GA (1998) Test bolus examination in the carotid artery at dynamic gadolinium-enhanced MR angiography. Radiology 206:283–289
Heverhagen JT, Funck RC, Schwarz U et al (2001) Kinetic evaluation of an i.v. bolus of MR contrast media. Magn Reson Imaging 19:1025–1030
Morasch MD, Collins J, Pereles FS et al (2003) Lower extremity stepping-table magnetic resonance angiography with multilevel contrast timing and segmented contrast infusion. J Vasc Surg 37:62–71
Nael K, Ruehm SG, Michaely HJ et al (2007) Multistation whole-body high-spatial-resolution MR angiography using a 32-channel MR system. AJR Am J Roentgenol 188:529–539
Nael K, Fenchel M, Krishnam M, Laub G, Finn JP, Ruehm SG (2007) High-spatial-resolution whole-body MR angiography with high-acceleration parallel acquisition and 32-channel 3.0-T unit: initial experience. Radiology 242:865–872
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fenchel, M., Nael, K., Seeger, A. et al. Whole-body magnetic resonance angiography at 3.0 Tesla. Eur Radiol 18, 1473–1483 (2008). https://doi.org/10.1007/s00330-008-0885-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-008-0885-1